Eyebright Medical Technology Beijing Co Ltd
SSE:688050
Balance Sheet
Balance Sheet Decomposition
Eyebright Medical Technology Beijing Co Ltd
Current Assets | 1.1B |
Cash & Short-Term Investments | 733.2m |
Receivables | 168.4m |
Other Current Assets | 166.9m |
Non-Current Assets | 1.3B |
Long-Term Investments | 160.1m |
PP&E | 868.5m |
Intangibles | 168.6m |
Other Non-Current Assets | 92.9m |
Current Liabilities | 120.6m |
Accounts Payable | 19m |
Accrued Liabilities | 33.7m |
Other Current Liabilities | 67.9m |
Non-Current Liabilities | 253.3m |
Long-Term Debt | 171.2m |
Other Non-Current Liabilities | 82.2m |
Balance Sheet
Eyebright Medical Technology Beijing Co Ltd
Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|---|---|---|
Assets | |||||||
Cash & Cash Equivalents |
31
|
67
|
196
|
537
|
473
|
355
|
|
Cash |
0
|
0
|
0
|
0
|
473
|
350
|
|
Cash Equivalents |
31
|
67
|
196
|
537
|
0
|
5
|
|
Short-Term Investments |
0
|
203
|
0
|
453
|
485
|
482
|
|
Total Receivables |
43
|
50
|
67
|
88
|
90
|
118
|
|
Accounts Receivables |
35
|
45
|
58
|
74
|
68
|
104
|
|
Other Receivables |
8
|
5
|
9
|
14
|
22
|
15
|
|
Inventory |
17
|
36
|
61
|
59
|
56
|
79
|
|
Other Current Assets |
6
|
6
|
11
|
9
|
15
|
27
|
|
Total Current Assets |
96
|
362
|
335
|
1 146
|
1 119
|
1 061
|
|
PP&E Net |
95
|
138
|
202
|
286
|
604
|
795
|
|
PP&E Gross |
95
|
138
|
202
|
286
|
604
|
795
|
|
Accumulated Depreciation |
14
|
22
|
36
|
52
|
79
|
112
|
|
Intangible Assets |
56
|
57
|
101
|
113
|
128
|
140
|
|
Goodwill |
0
|
0
|
0
|
0
|
21
|
21
|
|
Long-Term Investments |
16
|
15
|
16
|
41
|
101
|
151
|
|
Other Long-Term Assets |
14
|
15
|
33
|
53
|
75
|
76
|
|
Other Assets |
0
|
0
|
0
|
0
|
21
|
21
|
|
Total Assets |
276
N/A
|
587
+112%
|
686
+17%
|
1 639
+139%
|
2 048
+25%
|
2 245
+10%
|
|
Liabilities | |||||||
Accounts Payable |
0
|
0
|
0
|
2
|
6
|
14
|
|
Accrued Liabilities |
7
|
10
|
14
|
18
|
32
|
43
|
|
Short-Term Debt |
10
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
6
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
21
|
8
|
9
|
57
|
102
|
91
|
|
Total Current Liabilities |
38
|
24
|
23
|
77
|
139
|
148
|
|
Long-Term Debt |
28
|
0
|
0
|
0
|
155
|
163
|
|
Deferred Income Tax |
0
|
0
|
0
|
0
|
1
|
4
|
|
Minority Interest |
0
|
3
|
30
|
30
|
66
|
60
|
|
Other Liabilities |
11
|
9
|
15
|
14
|
12
|
10
|
|
Total Liabilities |
78
N/A
|
36
-54%
|
68
+92%
|
120
+77%
|
374
+210%
|
384
+3%
|
|
Equity | |||||||
Common Stock |
61
|
79
|
79
|
105
|
105
|
105
|
|
Retained Earnings |
29
|
9
|
11
|
108
|
250
|
444
|
|
Additional Paid In Capital |
167
|
481
|
528
|
1 305
|
1 318
|
1 311
|
|
Total Equity |
198
N/A
|
551
+178%
|
618
+12%
|
1 518
+146%
|
1 674
+10%
|
1 860
+11%
|
|
Total Liabilities & Equity |
276
N/A
|
587
+112%
|
686
+17%
|
1 639
+139%
|
2 048
+25%
|
2 245
+10%
|
|
Shares Outstanding | |||||||
Common Shares Outstanding |
61
|
79
|
79
|
105
|
105
|
105
|